News Desk, AnyTV, New Delhi
Published by: Amit Mandal
Updated Mon, 21 Feb 2022 06:31 PM IST
Summary
Corbevax has received emergency use approval from India’s drug regulator for use in the age group of 12 to 18 years.
hear the news
hear the news
Biological E Ltd informed that Corbevax, India’s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19 for use in the age group of 12 to 18 years, has received emergency use from the drug regulator of India. approval has been obtained.
Government is buying 30 crore doses
Last year, the government had made an advance payment of 1500 crores to Hyderabad-based company Biological E for the purchase of these vaccines. On 14 February itself, the Drug Controller of India (DGCI) allowed the emergency use of Corbevax vaccine for children between 12 and 18 years. Official sources had told ANI that the price of Corbevax would probably be Rs 145. It does not include tax.
RBD protein based vaccine
According to the Union Health Ministry, this vaccine is India’s first RBD protein based COVID-19 vaccine. This is the second vaccine after Bharat Biotech’s Covaxin, to be administered to children below the age of 18 years.
What Corbewax Characteristics of the vaccine?
Corbevax vaccine is administered intramuscularly. Two doses are given at an interval of 28 days. Corbevax is available in 0.5 ml (single dose) and 5 ml (ten doses) vials. It is preserved at 2 to 8 °C.
Expansion
Biological E Ltd informed that Corbevax, India’s first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19 for use in the age group of 12 to 18 years, has received emergency use from the drug regulator of India. approval has been obtained.
Government is buying 30 crore doses
Last year, the government had made an advance payment of 1500 crores to Hyderabad-based company Biological E for the purchase of these vaccines. On 14 February itself, the Drug Controller of India (DGCI) allowed the emergency use of Corbevax vaccine for children between 12 and 18 years. Official sources had told ANI that the price of Corbevax would probably be Rs 145. It does not include tax.
RBD protein based vaccine
According to the Union Health Ministry, this vaccine is India’s first RBD protein based COVID-19 vaccine. This is the second vaccine after Bharat Biotech’s Covaxin, to be administered to children below the age of 18 years.
What Corbewax Characteristics of the vaccine?
Corbevax vaccine is administered intramuscularly. Two doses are given at an interval of 28 days. Corbevax is available in 0.5 ml (single dose) and 5 ml (ten doses) vials. It is preserved at 2 to 8 °C.